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1. Introduction {#efs25679-sec-0002}
===============

1.1. Background and Terms of Reference as provided by the requestor {#efs25679-sec-0003}
-------------------------------------------------------------------

Before a substance is authorised to be used in food contact materials (FCM) and is included in a positive list EFSA\'s opinion on its safety is required. This procedure has been established in Articles 8, 9 and 10 of Regulation (EC) No 1935/2004[1](#efs25679-note-1007){ref-type="fn"} of the European Parliament and of the Council of 27 October 2004 on materials and articles intended to come into contact with food.

According to this procedure, the industry submits applications to the Member States' competent authorities which transmit the applications to the European Food Safety Authority (EFSA) for their evaluation.

In this case, EFSA received an application from Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL), requesting the evaluation of the substance phosphorous acid, triphenyl ester, polymer with alpha‐hydro‐omega‐hydroxypoly\[oxy(methyl‐1,2‐ethanediyl)\], C10--16 alkyl esters, with the CAS number 1227937‐46‐3 and the FCM substance No 1076. The dossier was submitted on behalf of Dover Chemical Corporation.

According to Regulation (EC) No 1935/2004 of the European Parliament and of the Council on materials and articles intended to come into contact with food, EFSA is asked to carry out an assessment of the risks related to the intended use of the substance and to deliver a scientific opinion.

2. Data and methodologies {#efs25679-sec-0004}
=========================

2.1. Data {#efs25679-sec-0005}
---------

The applicant has submitted a dossier in support of their application for the authorisation of phosphorous acid, triphenyl ester, polymer with alpha‐hydro‐omega‐hydroxypoly\[oxy(methyl‐1,2‐ethanediyl)\], C10--16 alkyl esters, to be used in plastic food contact materials.

Additional information was provided by the applicant during the assessment process in response to requests from EFSA sent on 4 December 2018 (see 'Documentation provided to EFSA').

Data submitted and used for the evaluation are: **Non‐toxicological data and information**Chemical identityDescription of the manufacturing processPhysical and chemical propertiesIntended useExisting authorisation(s)Migration of the substanceResidual content of the substance in the plasticOligomersIdentification, quantification and migration of reaction products and impurities**Toxicological data**Bacterial gene mutation test*In vitro* mammalian cell gene mutation test*In vitro* mammalian chromosome aberration test90‐day oral toxicity study in ratsMiscellaneous (immune, delayed neurotoxicity study)

2.2. Methodologies {#efs25679-sec-0006}
------------------

The assessment was conducted in line with the principles laid down in Regulation (EC) No 1935/2004 on materials and articles intended to come into contact with food. This Regulation underlines that applicants may consult the Guidelines of the Scientific Committee on Food (SCF) for the presentation of an application for safety assessment of a substance to be used in FCM prior to its authorisation (European Commission, [2001](#efs25679-bib-0003){ref-type="ref"}), including the corresponding data requirements. The dossier that the applicant submitted for evaluation was in line with the SCF guidelines (European Commission, [2001](#efs25679-bib-0003){ref-type="ref"}).

The methodology is based on the characterisation of the substance that is the subject of the request for safety assessment prior to authorisation, its impurities and reaction and degradation products, the evaluation of the exposure to those substances through migration and the definition of minimum sets of toxicity data required for safety assessment.

To establish the safety from ingestion of migrating substances, the toxicological data indicating the potential hazard and the likely human exposure data need to be combined. Exposure is estimated from studies on migration into food or food simulants and considering that a person may consume daily up to 1 kg of food in contact with the relevant FCM.

As a general rule, the greater the exposure through migration, the more toxicological data is required for the safety assessment of a substance. Currently there are three tiers with different thresholds triggering the need for more toxicological information as follows: In case of high migration (i.e. 5--60 mg/kg food), an extensive data set is needed.In case of migration between 0.05 and 5 mg/kg food, a reduced data set may suffice.In case of low migration (i.e. \< 0.05 mg/kg food), only a limited data set is needed.

More detailed information on the required data is available in the SCF guidelines (European Commission, [2001](#efs25679-bib-0003){ref-type="ref"}).

The assessment was conducted in line with the principles described in the EFSA Guidance on transparency in the scientific aspects of risk assessment (EFSA, [2009](#efs25679-bib-0002){ref-type="ref"}) and considering the relevant guidance from the EFSA Scientific Committee.

3. Assessment {#efs25679-sec-0007}
=============

According to the applicant, the substance 'phosphorous acid, triphenyl ester, polymer with alpha‐hydro‐omega‐hydroxypoly\[oxy(methyl‐1,2‐ethanediyl)\], C10--16 alkyl esters' is a polymeric additive to be used as a secondary antioxidant/stabiliser at up to 0.2% w/w in high impact polystyrene (HIPS). The plastic, in the form of films and articles, is intended for contact with aqueous, acidic, low‐alcohol and fatty foods for long‐term storage at room temperature and below, after hot‐fill and/or heating up to 100°C for maximum 2 h.

3.1. Non‐toxicological data {#efs25679-sec-0008}
---------------------------

Chemical formula:$$A\left\lbrack {\left\lbrack {- \text{CH}\left( {CH_{3}} \right) - CH_{2} - O} \right\rbrack_{x} - P\left( \text{OR} \right) - O} \right\rbrack_{y} - B$$

where:

R = aliphatic C10--16

A = HO-- or (RO)~2~P--

B = R-- or HO--CH~2~--CH(CH~3~)--

x = 2--100

y = 1 to at least 500

The substance 'phosphorous acid, triphenyl ester, polymer with alpha‐hydro‐omega‐hydroxypoly\[oxy(methyl‐1,2‐ethanediyl)\], C10--16 alkyl esters' is a polymeric additive, obtained by reaction of ■■■■■, with a molecular weight distribution ranging from ■■■■■. The averaged molecular weight (Mw) and number average molecular weight (Mn) values are in the range of ■■■■■ and ■■■■■, respectively. The fraction below 1,000 Da is ■■■■■.

The purity of the substance is about 96%, which is derived from the determination of the known impurities and subtraction of them from 100%. Impurity levels in the substance are: ■■■■■.

The substance is lipophilic with log P~o/w~\'s for the individual constituents greater than 9. It is not soluble in water, 10% ethanol or 3% acetic acid, but very soluble in solvents such as hexane or toluene. The additive has no defined melting point and no boiling point.

The maximum processing temperature of HIPS containing the additive is 260°C. By thermogravimetric analysis (TGA), the onset of thermal decomposition was around 310°C, although some loss in mass started at 220°C. Taking into account evaporation of volatiles, and the short heat treatment in processing, the Panel concluded that the additive has sufficient thermal stability for the use in HIPS.

In 10% ethanol, the substance hydrolyses slowly into substances already listed in Regulation (EU) 10/2011. Hydrolysis in gastric juice simulant over several hours at 37°C reached ■■■■■. In performing its role as an antioxidant/stabiliser, oxidation of the substance into the phosphate form takes place during melt processing of the HIPS. The phosphate form is stable against hydrolysis.

Migration tests were carried out from a HIPS sample containing the substance at 0.2% using 10% and 95% ethanol at 100°C for 2 h followed by 30 days at 40°C. The migration was estimated based on the determination of total phosphorous by inductively coupled plasma optical emission spectrometry (ICP‐OES). The calculation of the substance concentration from the measured phosphorous migration used a conversion factor derived from the known phosphorous content of the substance of ■■■■■[2](#efs25679-note-1008){ref-type="fn"}. The migration of the substance reached 0.001 mg/kg in 10% ethanol and 0.1 mg/kg in 95% ethanol. The considerably higher migration into 95% ethanol can be explained by strong interaction with the plastic which can give rise to exaggerated migration (FDA, [2007](#efs25679-bib-0004){ref-type="ref"}; Genualdi et al., [2014](#efs25679-bib-0005){ref-type="ref"}). The Panel noted that the migration into foodstuffs according to the intended use, including fatty foods, will be substantially lower due to weak interactions, if any, between the food and the plastic. No migration tests into 3% acetic acid were performed, but taking into account the low solubility and that in tests with linear low‐density polyethylene (LLDPE) the migration was lower than in 10% ethanol, migration into the acidic food simulant is expected to be ≤ 0.001 mg/kg.

Regarding the products of thermal degradation under processing conditions, qualitative migration tests were performed using ■■■■■ containing the substance at ■■■■■ and a primary antioxidant at ■■■■■. The samples were extruded at up to ■■■■■, i.e. at higher temperatures than applied in HIPS processing. Migration was tested with isooctane for 1.5 h at 60°C followed by 48 h at 40°C. ■■■■■ were detected and identified.

No comprehensive compositional analysis of the low molecular mass fraction of the substance and the degradation products was provided, but all phosphorous‐containing substances were included in the migration measurements.

Theoretical maximum possible migration of reaction and breakdown products as well as non‐reacted starting substances was calculated as 100% migration from a HIPS specimen of 250 μm thickness. For the components not containing phosphorous, that are listed in Regulation (EU) 10/2011, are either without any restriction (■■■■■), or the worst‐case migration has been estimated to be well below the respective SML value (■■■■■). The complete migration of the phosphorous‐containing impurity (■■■■■) from HIPS would amount to ■■■■■ food, but the Panel estimated that, based on generally recognised migration modelling (Hoekstra et al., [2005](#efs25679-bib-0006){ref-type="ref"}), the amount actually migrating would be at least one order of magnitude lower and part of it is oxidised to ■■■■■ during manufacturing. Complete migration of the ■■■■■ would amount to ■■■■■. Similarly, real migration of ■■■■■ from HIPS would be at least one order of magnitude lower.

3.2. Toxicological data {#efs25679-sec-0009}
-----------------------

### 3.2.1. Genotoxicity {#efs25679-sec-0010}

**The substance was tested in three** ***in vitro*** **genotoxicity tests with and without metabolic activation**

A bacterial reverse mutation assay (Ames test) was made according to OECD TG 471. Four strains of *Salmonella* Typhimurium (TA1535, TA1537, TA98 and TA100) and *Escherichia coli* WP2 *uvrA* were used in the presence or absence of S9 mix. Two experiments were performed in which eight concentrations (3, 10, 33, 100, 333, 1,000, 2,500 and 5,000 μg/plate) were tested in triplicate employing the plate incorporation and the pre‐incubation method, respectively. No cytotoxicity, evident as reduction in number of revertants, was observed at any concentration of the test substance. No increase in revertant colony number of any of the tester strains was observed following treatment with the substance.

The substance was tested in gene mutation studies at the thymidine‐kinase (TK) locus using mouse lymphoma assay following the OECD TG 476. Two separate experiments were performed in which six concentrations were tested (namely, ■■■■■ 5,000 and ■■■■■ μg/ml for 4 h and 24 h treatment, respectively with and without S9). ■■■■■. No increase of the mutation frequency was noted in both experiments with and without metabolic activation.

An *in vitro* mammalian chromosomal aberration test in Chinese Hamster V79 cells was carried out according to OECD TG 473. Cell cultures were exposed for 4 +14h recovery to the substance at ■■■■■ 5,000 μg/ml without S9, and at ■■■■■ 5,000 μg/ml with S9 and for 18h continuous treatment at ■■■■■ without S9. Cytotoxicity as reduction in mitotic index was observed at the highest concentrations tested (■■■■■ without S9). The frequency of structural and numerical chromosomal aberrations in treated cultures was comparable to the values detected in negative controls.

**The phosphate form of the substance was also tested in three** ***in vitro*** **genotoxicity tests with and without metabolic activation**

A bacterial reverse mutation assay (Ames test) was made according to OECD TG 471. The phosphate form of the substance was tested using the *S. *Typhimurium strains TA1535, TA1537, TA98, TA100, and the *E. coli* strain WP2 *uvrA*. The assay was performed in triplicate in two independent experiments both with and without S9 at the following concentrations in both experiments: 3, 10, 33, 100, 333, 1,000, 2,500 and 5,000 μg/plate. No cytotoxicity, evident as reduction in number of revertants, was observed at any concentration of the test substance in both experiments. No increase in revertant colony number of any of the tester strains was observed following treatment with the substance.

The substance was tested for gene mutation at the TK locus using mouse lymphoma assay following the OECD TG 476. Six concentrations of the substance were tested (namely, ■■■■■ at 4 h treatment without S9 and ■■■■■ μg/ml for 4 h treatment with S9 and 24 h treatment with and without S9). ■■■■■. No increase of the mutation frequency was noted in both experiments with and without metabolic activation.

An *in vitro* mammalian chromosomal aberration test in Chinese Hamster V79 cells was carried out according to OECD TG 473. Cell cultures were exposed for 4h+14h recovery to the substance at ■■■■■ 4,852.8 μg/ml with S9 and for 18 h continuous treatment at ■■■■■ without S9. Cytotoxicity as reduction in mitotic index was observed at the highest concentrations tested (■■■■■ for 4 h treatment with S9). The frequency of structural and numerical chromosomal aberrations in treated cultures was comparable to the values detected in negative controls.

**Concluding remarks on genotoxicity**

The Panel noted that genotoxicity assays were carried out with the substance and its phosphate form covering the whole Mw range, rather than with the LMW fraction (\< 1,000 Da). In general, the LMW fraction is considered of highest toxicological relevance as substances with Mw \> 1,000 Da are poorly absorbed in the gastrointestinal tract. However, the dose‐related cytotoxicity observed under *in vitro* test conditions indicated that test organisms (bacteria and cells) were adequately exposed to test material under *in vitro* test conditions. The Panel also noted that for genotoxicity read‐across from fractions with different Mw would be justified, as genotoxicity relies on the presence of functional groups common across oligomers of different mass, and therefore the negative results obtained with the bulk substance would also specifically apply to the LMW fraction.

According to the Note for Guidance (EFSA, [2008](#efs25679-bib-0001){ref-type="ref"}), genotoxicity tests with polymeric additives are not generally considered necessary when starting substances are not genotoxic. In case of this polymeric additive, starting substances are either listed in Regulation (EU) 10/2011 ■■■■■ or evaluated as non‐genotoxic (■■■■■). Furthermore, the Panel noted that no additional functional groups raising concerns for genotoxicity are generated during the manufacturing process.

### 3.2.2. Subchronic toxicity {#efs25679-sec-0011}

A LMW version of the substance in the phosphate form was synthesised, ■■■■■, for the subchronic toxicity testing. Based on the information provided on the method used for synthesis and the analytical data on the synthetic mix, the Panel concluded that this mixture was sufficiently representative of the LMW fraction of the substance. The LMW fraction was used to allow better absorption by the gastrointestinal tract. The synthetic mixture was tested in a 90‐day dietary toxicity study in Wistar rats at the target dose levels of 15, 50, 150 and 500 mg/kg body weight (bw) per day including a recovery group (4 weeks). No deaths or clinical signs (daily or weekly) of toxicological relevance and no changes in body weight, daily food consumption, ophthalmological findings and no macroscopical changes at necropsy were observed. Results from the Functional Observational Battery (FOB) did not indicate any effects of neurotoxicological relevance (including mean fore‐ or hind‐limb grip strength, body temperature, landing foot splay and locomotor activity including rearing). Increases in relative liver weights along with microscopic changes (increased incidence of single cell necrosis) were found in males and females at 150 and 500 mg/kg bw per day. At 500 mg/kg bw per day, fine periportal vacuolisation and an increased severity of inflammatory cell foci were observed in the livers of males and females at terminal and recovery sacrifice. It was also noted that the test item (itself or as derivatives) might accumulate in macrophages (liver, spleen and mesenteric lymph node) and in Kupffer cells (liver) at and above 50 mg/kg bw per day, without reversibility after four weeks. The latter finding *per se* was not considered adverse by the Panel. In an additional part of the study, no effects of immunological relevance were noted in the primary immune response of female or male rats, nor did the leukocyte distribution show any effects.

The no observed adverse effect level (NOAEL) is considered to be 50 mg/kg bw per day based on the liver effects in males and females at 150 and 500 mg/kg bw per day.

### 3.2.3. Neurotoxicity {#efs25679-sec-0012}

In a delayed neurotoxicity study (OECD TG No 418) with a LMW fraction of the phosphate form of the substance, a limit dose of 2,000 mg/kg bw in corn oil was applied to hens (n = 15) by oral gavage. The test item neither inhibited neuropathy target esterase (NTE) activity (at 24 and 48 h) nor induced gross lesions or histopathological changes in different brain areas compared to vehicle controls. To develop positive control data, hens were treated with tri‐*ortho*‐cresyl phosphate (TOCP). The TOCP‐treated hens (n = 15; oral gavage, single dose of 750 mg/kg bw) exhibited an approximately threefold lower NTE activity in the brain and lumbar spinal cord (at 24 and 48 h) as well as typical locomotor ataxia and histopathological changes indicative of organophosphate induced delayed neurotoxicity. In conclusion, the data do not provide any evidence of induction of delayed neurotoxicity by the LMW fraction of the phosphate form of the substance.

### 3.2.4. Concluding remarks on toxicity {#efs25679-sec-0013}

The Panel noted that the accumulation potential was not fully addressed by the applicant. Therefore, notwithstanding the availability of the 90‐day subchronic toxicity study and the evidence for lack of neurotoxicity, it was considered prudent to conclude on the safety based on the lack of genotoxicity, which according to the tiered approach gives rise to a migration restriction of 0.05 mg/kg food.

The Panel concluded that the phosphorous‐containing oligomers and other reaction/degradation products are adequately represented by the toxicity studies provided. The components not containing phosphorous (■■■■■) are listed in Regulation (EU) 10/2011. The ■■■■■, which is expected to migrate at less than 0.001 mg/kg, is reported to be not mutagenic in the Ames test (NTP, [2018](#efs25679-bib-0007){ref-type="ref"}). The Panel noted that there are no alerts for genotoxicity in the ■■■■■

4. Conclusions {#efs25679-sec-0014}
==============

The CEP Panel, after having considered the above‐mentioned data, concluded that the substance phosphorous acid, triphenyl ester, polymer with alpha‐hydro‐omega‐hydroxypoly\[oxy(methyl‐1,2‐ethanediyl)\], C10--16 alkyl ester, does not raise a safety concern for the consumer if it is used as an additive in HIPS materials and articles intended for contact with aqueous, acidic, low‐alcohol and fatty foods, for long‐term storage at room temperature and below, including hot‐fill and/or heating up to 100°C for up to 2 h, and if its migration does not exceed 0.05 mg/kg food.

Documentation provided to EFSA {#efs25679-sec-0015}
==============================

Initial dossier. May 2018. Submitted on behalf of Dover Chemical Corporation.Additional data. February 2019. Submitted on behalf of Dover Chemical Corporation.

Abbreviations {#efs25679-sec-0016}
=============

bwbody weightBVLBundesamt für Verbraucherschutz und LebensmittelsicherheitCASChemical Abstracts ServiceCEP PanelEFSA Panel on Food Contact Materials, Enzymes and Processing AidsFCMfood contact materialsFOBFunctional Observational BatteryHIPShigh impact polystyreneICP‐OESinductively coupled plasma optical emission spectrometryLLDPElinear low‐density polyethyleneLMWlow molecular weightMnnumber average molecular weightMwmolecular weightNOAELno observed adverse effect levelNTEneuropathy target esteraseOECDOrganisation for Economic Co‐operation and DevelopmentP~o/w~octanol/water partition coefficientSCFScientific Committee on FoodSMLspecific migration limitTGAthermogravimetric analysisTKthymidine‐kinaseTOCPtri‐*ortho*‐cresyl phosphatew/wweight by weight

Regulation (EC) No 1935/2004 of the European parliament and of the council of 27 October 2004 on materials and articles intended to come into contact with food and repealing Directives 80/590/EEC and 89/109/EEC. OJ L 338, 13.11.2004, p. 4--17.

No specific method of analysis in food was provided, but a method based on the determination of the total phosphorous content in food simulants multiplying it by a factor of ■■■■■. Migration modelling can be used in order to estimate the migration of the substance based on the content of the low molecular part of the substance in the polymer measured as such.
